{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:44:32Z","timestamp":1792453472447,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.atherosclerosis.2013.01.022","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T22:31:03Z","timestamp":1359498663000},"page":"429-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":193,"title":["Nonalcoholic fatty liver disease and serum lipoproteins: The\u00a0Multi-Ethnic Study of Atherosclerosis"],"prefix":"10.1016","volume":"227","author":[{"given":"Andrew Paul","family":"DeFilippis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurram","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a01","key":"10.1016\/j.atherosclerosis.2013.01.022_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000088231","article-title":"The metabolic syndrome and type 2 diabetes: epidemiological figures and country specificities","volume":"20","author":"Procopiou","year":"2005","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib2","first-page":"560","article-title":"Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations","volume":"11","author":"Younossi","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib3","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib4","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib6","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3748\/wjg.v13.i10.1579","article-title":"Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease","volume":"13","author":"Hamaguchi","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/hep.23135","article-title":"Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels","volume":"50","author":"Haring","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib8","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.2337\/diabetes.54.12.3541","article-title":"Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients","volume":"54","author":"Targher","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib9","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib10","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in\u00a0adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib11","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","article-title":"Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults","volume":"164","author":"Kim","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib12","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2337\/dc06-0455","article-title":"Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes","volume":"29","author":"Toledo","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11892-008-0011-4","article-title":"Fatty liver, insulin resistance, and dyslipidemia","volume":"8","author":"Adiels","year":"2008","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib14","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2337\/dc07-1088","article-title":"Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state","volume":"30","author":"Cali","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2337\/dc07-1558","article-title":"Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions","volume":"31","author":"Kantartzis","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2010.01.008","article-title":"Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations","volume":"52","author":"Lee","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2214\/ajr.142.4.741","article-title":"Quantitative evaluation of fatty liver by computed tomography in rabbits","volume":"142","author":"Kawata","year":"1984","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1148\/radiology.137.3.6934563","article-title":"Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease","volume":"137","author":"Piekarski","year":"1980","journal-title":"Radiology"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004424-199304000-00006","article-title":"Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography","volume":"28","author":"Longo","year":"1993","journal-title":"Invest Radiol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1148\/radiol.2391050361","article-title":"Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment","volume":"239","author":"Park","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/aje\/kwf113","article-title":"Multi-ethnic study of atherosclerosis: objectives and design","volume":"156","author":"Bild","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib23","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib24","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib25","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib26","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","article-title":"Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus","volume":"112","author":"Wilson","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib27","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.96.8.2520","article-title":"Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction","volume":"96","author":"Gaziano","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.numecd.2008.09.003","article-title":"Triglyceride\/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men","volume":"19","author":"Hadaegh","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1148\/radiol.2341040439","article-title":"Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"234","author":"Carr","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.acra.2012.02.022","article-title":"Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis","volume":"19","author":"Zeb","year":"2012","journal-title":"Acad Radiol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib31","first-page":"108","article-title":"Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases","volume":"9","author":"Zeng","year":"2008","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0026-0495(77)90020-8","article-title":"Hepatic lipid metabolism in severe human obesity","volume":"26","author":"Kral","year":"1977","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/jhep.2002.30690","article-title":"Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association","volume":"35","author":"Pagano","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib35","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib36","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/ATVBAHA.109.202275","article-title":"Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesity","volume":"30","author":"Chan","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib37","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1053\/jhep.2003.50132","article-title":"Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis","volume":"37","author":"Musso","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib38","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/hep.23094","article-title":"Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis","volume":"50","author":"Fujita","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib39","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.amjmed.2004.12.021","article-title":"Low HDL-C: a secondary target of dyslipidemia therapy","volume":"118","author":"Rosenson","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib42","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archinternmed.2008.594","article-title":"Hypertriglyceridemia and its pharmacologic treatment among US adults\u2013invited commentary","volume":"169","author":"Thompson","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib43","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.0000033222.75187.B9","article-title":"Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women","volume":"106","author":"Blake","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib44","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jacl.2007.10.001","article-title":"LDL particle number and risk of future cardiovascular disease in the Framingham Offspring study \u2013 implications for LDL management","volume":"1","author":"Cromwell","year":"2007","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib45","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1161\/01.ATV.0000022015.97341.3A","article-title":"Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study","volume":"22","author":"Kuller","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib46","doi-asserted-by":"crossref","first-page":"71i","DOI":"10.1016\/S0002-9149(02)02636-X","article-title":"Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study","volume":"90","author":"Mackey","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2006.05.007","article-title":"LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"192","author":"Mora","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib48","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/CIRCULATIONAHA.105.565135","article-title":"Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial","volume":"113","author":"Otvos","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0002-9149(02)02427-X","article-title":"Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial","volume":"90","author":"Rosenson","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1096\/fasebj.8.1.8299884","article-title":"Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men","volume":"8","author":"Dreon","year":"1994","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.ATV.13.2.147","article-title":"Effect of hepatic lipase on LDL in normal men and those with coronary artery disease","volume":"13","author":"Zambon","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib52","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/01.ATV.18.11.1723","article-title":"Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol","volume":"18","author":"Zambon","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib53","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1161\/01.CIR.99.15.1959","article-title":"Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density","volume":"99","author":"Zambon","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrendo.2010.50","article-title":"Diagnosis and treatment of apolipoprotein B dyslipoproteinemias","volume":"6","author":"Sniderman","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib55","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1185\/030079906X104696","article-title":"Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study","volume":"22","author":"Athyros","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib56","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","article-title":"Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis","volume":"376","author":"Athyros","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2013.01.022_bib57","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","article-title":"Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials","volume":"55","author":"Musso","year":"2012","journal-title":"Diabetologia"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T10:47:06Z","timestamp":1595328426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0021915013000580"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.01.022","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic fatty liver disease and serum lipoproteins: The\u00a0Multi-Ethnic Study of Atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}